Uploaded image for project: 'FHIR Specification Feedback'
  1. FHIR Specification Feedback
  2. FHIR-26945

clarifying 'context' vs 'risk-of' for associated phenotype and/or associated cancer component

    XMLWordPrintableJSON

    Details

    • Type: Change Request
    • Status: Triaged (View Workflow)
    • Priority: Medium
    • Resolution: Persuasive with Modification
    • Specification:
      Genomics Reporting (FHIR)
    • Raised in Version:
      1.0
    • Work Group:
      Clinical Genomics
    • Related Page(s):
      genomics
    • Resolution Description:
      Hide

      remove 'associated-cancer' component from diagnostic implication to eliminate confusion.

      rename 'associated-cancer' component on therapeutic implication to 'contextual-indication'

      option 1. remove 'associated-phenotype' component from therapeutic implication

       

      Show
      remove 'associated-cancer' component from diagnostic implication to eliminate confusion. rename 'associated-cancer' component on therapeutic implication to 'contextual-indication' option 1. remove 'associated-phenotype' component from therapeutic implication  

      Description

      In the Genomics FHIR IG the fields of associated cancer and associated phenotype components do not have clear guidance on how to distinguish 'risk of' versus 'context.' Perhaps, the use of the component in therapeutic implication profile indicates 'context,' whereas the use of the component in diagnostic implication profile indicates 'risk of?'

      If necessary, maybe a flag would be appropriate? or some other modifier element could be added? 

        Attachments

          Activity

            People

            Assignee:
            Unassigned Unassigned
            Reporter:
            bheale Bret Heale
            Request in-person:
            Bret Heale
            Watchers:
            3 Start watching this issue

              Dates

              Created:
              Updated:
              Resolved: